Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.

@article{Karlsdttir2008LateGM,
  title={Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.},
  author={Asa Karlsd{\'o}ttir and Ludvig P. Muren and Tore Wentzel-Larsen and Olav Dahl},
  journal={International journal of radiation oncology, biology, physics},
  year={2008},
  volume={70 5},
  pages={1478-86}
}
PURPOSE To investigate the incidence, time course, and relation to irradiated volumes of late morbidity after three-dimensional conformal radiation therapy (RT) for prostate cancer. METHODS AND MATERIALS From January 2000 to December 2001, a total of 247 patients with prostate cancer received a target dose of 70 Gy using conformal RT. Forty-eight patients… CONTINUE READING